AstraZeneca shares dropped as a lot as 7% on Monday after experiences that the corporate had discussed a potential mega-merger with Bristol Myers Squibb, a deal that analysts mentioned can be a stunning strategic transfer for one of many pharmaceutical trade’s strongest development tales. If accomplished, a deal may worth the businesses at roughly $400…
Intellia Therapeutics, constructing exterior and firm signal, Cambridge, Massachusetts, USA. Spencer Grant | Universal Images Group | Getty Images Intellia Therapeutics mentioned its Crispr-based treatment for a uncommon swelling situation met its objectives in a late-stage trial, marking a milestone for the sphere of gene editing and placing the corporate on observe to hunt approval…
If you’re questioning whether or not Regeneron Pharmaceuticals at round US$766 per share nonetheless presents worth, the reply is determined by the way you take a look at what the market is pricing in immediately. The inventory not too long ago closed at US$766.02, with returns of two.7% over 7 days, 3.3% over 30 days,…
UnitedHealthcare signal is displayed at its workplace constructing in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Tuesday posted first-quarter earnings that topped estimates and hiked its 2026 revenue outlook, as the corporate higher manages excessive medical prices and streamlines its operations. The nation’s largest personal insurer mentioned it expects…
Eli Lilly is spending $3.25 billion to accumulate Kelonia Therapeutics, a small biotech firm growing cell therapies for most cancers and autoimmune ailments, the businesses introduced Monday. Lilly might pay extra if Kelonia achieves specified scientific, regulatory, and business milestones. The acquisition is a boon for the small startup, which has subsisted on $60 million…
The Eli Lilly brand seems on the corporate’s workplace in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech firm Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly pays $3.25 billion upfront, and the remaining funds are contingent upon scientific, regulatory…
Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to decide on a everlasting chief of the embattled well being company. Schwartz should be confirmed by the Senate,…
After years of attempting to shed some pounds “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t enough.” Zuckerman, a 32-year-old information analyst based mostly in Washington, D.C., mentioned she misplaced 90 kilos in school and spent years biking via nutritionists, remedy and strict routines — solely to discover herself at…
The firm, which specialises in containment and supply options for injectable medicines, now employs over 1,400 individuals in Ireland throughout its Dublin and Waterford websites Pharmaceutical manufacturing business, cleanroom for course of gear, Manufacturing business in setting managed room West Pharamaceuticals has created 330 jobs as as a part of the growth of its manufacturing…
Pharma large Merck is shopping for U.S. biotech agency Terns Pharmaceuticals for $6.7 billion, the corporate stated Wednesday. This is the third multibillion-dollar acquisition for Merck over the previous yr as the corporate appears to bulk up its portfolio forward of its best-selling cancer drug Keytruda dropping patent safety in 2028. Merck will purchase Terns…